Zobrazeno 1 - 10
of 135
pro vyhledávání: '"Sang Bum Kang"'
Autor:
Young Su Park, Sang Bum Kang, Ronald R. Marchelletta, Harrison M. Penrose, Roos Ruiter-Visser, Barbara Jung, Michael J. Docherty, Brigid S. Boland, William J. Sandborn, Declan F. McCole
Publikováno v:
Pharmaceutics, Vol 15, Iss 3, p 811 (2023)
The prostone analog, lubiprostone, is approved to manage constipation-predominant irritable bowel syndrome. Lubiprostone also protects intestinal mucosal barrier function in animal models of colitis. The aim of this study was to determine if lubipros
Externí odkaz:
https://doaj.org/article/5f068f2b880b4b1ab6c054eb34c860c1
Autor:
Eun Ae Kang, Jongha Jang, Chang Hwan Choi, Sang Bum Kang, Ki Bae Bang, Tae Oh Kim, Geom Seog Seo, Jae Myung Cha, Jaeyoung Chun, Yunho Jung, Hyun Gun Kim, Jong Pil Im, Sangsoo Kim, Kwang Sung Ahn, Chang Kyun Lee, Hyo Jong Kim, Min Suk Kim, Dong Il Park
Publikováno v:
Journal of Clinical Medicine, Vol 10, Iss 4, p 633 (2021)
Early intestinal resection in patients with Crohn’s disease (CD) is necessary due to a severe and complicating disease course. Herein, we aim to predict which patients with CD need early intestinal resection within 3 years of diagnosis, according t
Externí odkaz:
https://doaj.org/article/a54b944c841940e3b820762b3f67e882
Autor:
Hyuk Yoon, Byong Duk Ye, Sang-Bum Kang, Kang-Moon Lee, Chang Hwan Choi, Joo-young Jo, Juwon Woo, Jae Hee Cheon
Publikováno v:
BMC Gastroenterology, Vol 24, Iss 1, Pp 1-11 (2024)
Abstract Background Tofacitinib is an oral Janus kinase inhibitor for the treatment of ulcerative colitis (UC). We aimed to identify the safety and effectiveness of tofacitinib in patients with UC in routine clinical settings in Korea. Methods This o
Externí odkaz:
https://doaj.org/article/19716eccc3444a97adb85097b1a70de5
Autor:
Jung Hyun Ji, Seung Hwan Shin, Yong Eun Park, Jihye Park, Jae Jun Park, Jae Hee Cheon, Tae Il Kim, Sang-Bum Kang, Sang Hyoung Park, Soo Jung Park, IBD Research Group of the Korean Association for the Study of Intestinal Diseases (KASID)
Publikováno v:
Intestinal Research, Vol 22, Iss 3, Pp 336-350 (2024)
Background/Aims The impact of vaccination on inflammatory bowel disease (IBD) patients is still unknown, and no studies have assessed the changes in patient-reported outcomes (PROs) after vaccination in patients with IBD. Therefore, in this study, we
Externí odkaz:
https://doaj.org/article/9fab05d6a34249ba97e8083fa077593b
Autor:
Jang Wook Lee, Chang Hwan Choi, Ji Hoon Park, Jeong Wook Kim, Sang Bum Kang, Ja Seol Koo, Young-Ho Kim, You Sun Kim, Young Eun Joo, Sae Kyung Chang
Publikováno v:
Intestinal Research, Vol 14, Iss 2, Pp 146-151 (2016)
Background/AimsAnti-tumor necrosis factor (TNF) therapy for active ulcerative colitis (UC) and Crohn's disease (CD) is associated with increased risks of tuberculosis (TB) infection. We analyzed the incidence and clinical features of Korean patients
Externí odkaz:
https://doaj.org/article/5faf8949155c42cebf063075588c361c
Autor:
Jun Su Lee1 umdalpin@hanmail.net, Sang-Bum Kang2 iamleejong@amc.seoul.kr, Kwangbeom Park1, Yong Sik Yoon3, Chang Sik Yu3, Sung Wook Hwang1, Byong Duk Ye1, Suk-Kyun Yang1, Jong Lyul Lee3, Sang Hyoung Park1
Publikováno v:
Intestinal Research. Jul2023, Vol. 21 Issue 3, p406-410. 5p.
Autor:
Shin-Hee Lee1, Sang-Bum Kang1 dxandtx@catholic.ac.kr
Publikováno v:
Clinical Endoscopy. May2023, Vol. 56 Issue 3, p388-390. 3p.
Autor:
Shine Hee Lee, Sang-Bum Kang
Publikováno v:
The Korean Journal of Medicine. 97:361-367
Inflammatory bowel disease includes two major types of disease: Crohn’s disease and ulcerative colitis. The incidence of inflammatory bowel disease is increasing worldwide, including in Korea. This chronic disease progresses gradually, with cycles
Publikováno v:
Asian Journal of Surgery. 45:2197-2202
Background Several studies have shown that there are no significant differences in anastomotic leakage associated with Transanal total mesorectal excision (taTME) versus laparoscopic TME (lapTME) for rectal cancer; however, little is known about late
Publikováno v:
BioMed Research International. 2022:1-6
Background. Patients with inflammatory bowel disease (IBD) have a decreased quality of life (QoL), the improvement of which is a treatment goal. The CUCQ-8 is a verified simple and effective QoL measurement tool. We validated the Korean version of CU